Hertlein L

No ORCID on file · 5 papers in corpus
observational 2018
The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium
PloS one ·doi:10.1371/journal.pone.0192881

AIM: The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and ß-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas. MATERIALS AND METHODS: 97 tumors were available for analysis of…

observational 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only
Oncology letters ·doi:10.3892/ol.2017.6592

The present study aimed to identify differences in protein expression in cases of endometrioid endometrial cancer (EEC) with and without coexisting adenomyosis uteri (AM), and to evaluate the histopathological and prognostic distinctions. T…

review 2012
[Unexplained pelvic pain: is it endometriosis?]
MMW Fortschritte der Medizin ·doi:10.1007/s15006-012-1007-1
diagnostic-accuracy 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
Clinical chemistry and laboratory medicine ·doi:10.1515/cclm.2011.709

BACKGROUND: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy. METHODS: We retr…

observational 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
Clinical chemistry and laboratory medicine ·doi:10.1515/CCLM.2009.134

BACKGROUND: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT). METHODS: All women diagnosed and treated for BOT at our institution between 1981 a…